what 5mg of bpc-157 looks like BPC-157, BPC-157/TB-500 BLEND 10MG (BPC-157 5mg/TB-500

Morrison et al., 2008

Lord et al., 2000)

Combination dosing produced greater reductions in body weight than semaglutide alone over 20 weeks, with a tolerability profile broadly consistent with each component

Research Highlights Phase 1 (12 weeks): Reductions between ~2.6% and ~11.3% Phase 2 (48 weeks): Lower-dose groups reached ~9% reductions Higher-dose and titration groups achieved ~20% reductions Control groups saw ~0.4% These outcomes place Eloralintide among the strongest-performing compounds within the amylin-pathway category

Dosing & Reconstitution Guide Educational guide for reconstitution and weekly dosing Standard / Gradual Titration (3 mL = ~3.33 mg/mL total) Route: Subcutaneous injection

Circulation 2001;103:919-25